Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512694 · ClinicalTrials.gov registry record
Duke Lupus Registry
A clinical trial of Systemic Lupus Erythematosus and Cutaneous Lupus, sponsored by Duke University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00512694: Recruiting study of Systemic Lupus Erythematosus and Cutaneous Lupus, sponsored by Duke University.
NCT00512694 is a study of Systemic Lupus Erythematosus and Cutaneous Lupus that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, above the 370-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (170% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00512694, a study of Systemic Lupus Erythematosus and Cutaneous Lupus, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-07 |
| Est. Completion | 2028-06 |
What NCT00512694 shows while recruiting
NCT00512694 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 370-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (170% higher).
The record links to 2 conditions, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 0 interventions.
NCT00512694 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00512694 about?
NCT00512694 is a clinical study titled "Duke Lupus Registry". Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (...
What is the current status of trial NCT00512694?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2007-07. Estimated completion is 2028-06.
What conditions does trial NCT00512694 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus, Cutaneous Lupus.
Who is sponsoring clinical trial NCT00512694?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00512694 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00512694's enrollment target sits among peer trials
1,000 6th of 99 higher than 91 of 99 other Systemic Lupus Erythematosus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Systemic Lupus Erythematosus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
RECRUITING · Phase 3
-
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
RECRUITING · Phase 1
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
RECRUITING
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia